3 Best Endocrinologists in New Haven, CT

“Dr. Silvio Inzucchi Specializes in the diagnosis and management of type 2 diabetes, insulin resistance, and cardiovascular complications, Dr. Inzucchi remains abreast of the latest research developments. He earned his medical degree from Harvard Medical School in 1985 and completed his residency, internship, and fellowship at Yale-New Haven Hospital. Graduating with a BS from Fordham University in 1981, Dr. Inzucchi holds board certifications in Internal Medicine from the AB of Internal Medicine (1988). With a focus on treating diabetes, pituitary disorders, and adrenal disorders, he currently practices at the Yale New Haven Health. Dr. Inzucchi is known for his adeptness at simplifying complex medical concepts, ensuring clear communication with his patients. New patients are welcomed to his practice, where they can benefit from his wealth of expertise and compassionate care.”

Read more

“Dr. Sonia D. Hegde graduated from Des Moines University; she completed her residency at Pennsylvania State University / Milton Hershey Medical Center and her fellowship at Stonybrook University in 2011. With over a decade of expertise in endocrinology, Dr. Sonia specializes in addressing various conditions, including Gestational Diabetes, Hyperparathyroidism, Hyperthyroidism, Hypothyroidism, and Thyroid Biopsy, among others. Affiliated with Yale-New Haven Hospital and Northeast Medical Group, Dr. Sonia is committed to dedicating ample time to actively listen to her patients, ensuring a thorough understanding of their concerns before formulating any treatment plan.”

Read more

“Dr. Kevan Herold earned his MD from Jefferson Medical College and completed his BS at Pennsylvania State University. Dr. Herold holds board certifications in Internal Medicine, Endocrinology & Metabolism (1985), and Internal Medicine (1982). With numerous publications to his credit, Dr. Herold specializes in treating both adult and pediatric patients with type 1 and type 2 diabetes, as well as diabetes resulting from cancer therapies and hypoglycemia. Notably, he served as the principal investigator for a groundbreaking clinical trial demonstrating the efficacy of teplizumab, a novel drug that can delay the onset of type 1 diabetes by two years. Additionally, Dr. Herold chairs the NIDDK TrialNet, a global consortium of researchers focused on type 1 diabetes. He holds the prestigious position of C.N.H. Long Professor of Immunobiology and Medicine (Endocrinology) at Yale School of Medicine.”

Read more